高级检索
当前位置: 首页 > 详情页

A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients

| 认领 | |

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究参与人:
研究单位: [1]Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. [2]Guangdong Province People's General Hospital [3]he First Affiliated Hospital of Bengbu Medical College,Bengbu,Anhui,China,233004 [4]Peking Union Medical College Hospital,Beijing,Beijing,China,100140 [5]Beijing Cancer Hospital,Beijing,Beijing,China,100192 [6]Beijing Chest Hospital,Capital Medical University,Beijing,Beijing,China,101149 [7]Guangdong Province People's General Hospital,Guangzhou,Guangdong,China,510080 [8]Nanfang Hospital, Southern Medical University,Guangzhou,Guangdong,China,510515 [9]Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center,Shenzhen,Guangdong,China,518116 [10]Affiliated Hospital of Hebei University,Baoding,Hebei,China,071000 [11]The Fourth Hospital of Hebei Medical University,Shijiazhuang,Hebei,China,050000 [12]Harbin Medical University Cancer Hospital,Harbin,Heilongjiang,China,150081 [13]The First Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan,China,450014 [14]Zhengzhou Central Hospital,Zhengzhou,Henan,China,450052 [15]The First Affiliated Hospital of Henan University of Science and Technology,Zhengzhou,Henan,China,471003 [16]Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology,Wuhan,Hubei,China,430022 [17]Union Hospital of Tongji Medical College, Huazhong University of Science and Technology,Wuhan,Hubei,China,430022 [18]Hubei Cancer Hospital,Wuhan,Hubei,China,430079 [19]Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University,Changsha,Hunan,China,410006 [20]The Central Hospital of Yongzhou,Yongzhou,Hunan,China,425006 [21]Jiangsu Province Hospital,Nanjing,Jiangsu,China,225001 [22]General Hospital of Xuzhou Mining Group,Xuzhou,Jiangsu,China,221006 [23]The second Affiliated Hospital of Nanchang University,Nanchang,Jiangxi,China,330006 [24]The First Hospital of Jilin University,Changchun,Jilin,China,130031 [25]Jilin Cancer Hospital,Jilin,Jilin,China,130021 [26]Yanbian University Affiliated Hospital,Yanji,Jilin,China,133000 [27]The first affiliated hospital of China medical university,Shenyang,Liaoning,China,110001 [28]Jinan Central Hospital,Jinan,Shandong,China,250013 [29]No. 960 Hospital of the Joint Service Support Force of Chinese People's Liberation Army,Jinan,Shandong,China,250031 [30]Shandong Provincial Qianfoshan Hospital,Jinan,Shandong,China,250061 [31]Linyi Cancer Hospital,Linyi,Shandong,China,276000 [32]Shanghai Chest Hospital,Shanghai Jiaotong University,Shanghai,Shanghai,China,200030 [33]Jieyang Peoples Hospital,Jieyang,Shanxi,China,522000 [34]West China Hospital,Sichuan University,Chengdu,Sichuan,China,610041 [35]The second peoples hospital of Neijiang,Neijiang,Sichuan,China,641100 [36]Tianjin Medical University General Hospital,Tianjin,Tianjin,China,300052 [37]Tianjin Medical University Cancer Hospital,Tianjin,Tianjin,China,300060 [38]Tianjin Peoples Hospital,Tianjin,Tianjin,China,350000 [39]The First Affiliated Hospital, Medical School of Zhejiang University,Hangzhou,Zhejiang,China,310009 [40]Zhejiang Provincial People's Hospital,Hangzhou,Zhejiang,China,310014 [41]SIR RUN RUN SHAW HOSPITAL Zhejiang University School of Medicine,Hangzhou,Zhejiang,China,310016 [42]Zhejiang Cancer Hospital,Hangzhou,Zhejiang,China,310022 [43]Shulan (Hangzhou) Hospital,Hangzhou,Zhengjiang,China,310000

关键词: ALK-rearranged ALK-positive ROS1-rearranged ROS1-positive

研究目的:
The study comprises two phases: phase I dose escalation (including PK run-in period and treatment period) and phase II study.

资源点击量:426 今日访问量:0 总访问量:408 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)